Tumor: Dogs with T-Cell and B-Cell Lymphomas
For more information: Click Here or CONTACT DR. MICHELE STEFFEY (530-752-1393) FOR INCLUSION IN THE STUDY.
Purpose of the Study The goal of this study is to evaluate the efficacy of using the enzyme Pegylated Arginine Deiminase (non-chemotherapy drug) as a subcutaneous injection. Eligibility Requirements:
Any prospective patient must be examined by the VMTH Oncology or Radiation Oncology service veterinarian, and require the following baseline evaluations at the owners expense before a dog can be considered for enrollment in the trial:
- Confirmed diagnosis
- Physical examination with weight recorded
- CBC, Chemistry Panel and Urinalysis All within two weeks of enrollment (referring blood work is acceptable as long as it was run at a commercial lab)